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Abstract: Marine polyketide natural products represent a fertile area 
of chemical space for the continual discovery of promising drug 
candidates. Advancements in spectroscopic and computational 
techniques have allowed for the increasingly facile structural and 
stereochemical determination of these biologically active molecules. 
However, their inherent architectural complexity often precludes a 
complete assignment even by the most discerning isolation chemists. 
This Minireview highlights how carefully conceived synthetic plans, 
employing highly stereocontrolled reactions, have enabled the 
configurational assignment of several polyketide natural products. 
1. Introduction 
The marine environment accounts for over 70% of the 
Earth’s total area and harbours a plethora of biodiversity.[1] This 
breadth of marine flora and fauna impacts the chemical diversity 
of secondary metabolites that many of these organisms produce. 
In facing the inherent problem of achieving efficacy in high dilution, 
many of these secondary metabolites produced by marine 
organisms have evolved over time to be highly potent binders of 
specific biological targets, or incredibly toxic defence mechanisms 
towards other living organisms.[2]  
Throughout history, humankind’s interdependence with 
nature has led to the extensive use of terrestrial natural products 
in treating diseases and ailments.[3] Largely owing to their 
comparative inaccessibility, marine natural products have only 
recently started to enter the medicinal repertoire.[4] Though 
marine natural products research has lagged behind that directed 
at terrestrial compounds, over 20,000 marine natural products 
have been discovered in the last 50 years.[5] Indeed, their diverse 
range of bioactivities have resulted in the clinical validation of 
many promising compounds.[6]  Underpinning further discovery, 
however, is the successful structural elucidation of these 
compounds of interest. In order to be realised as clinical 
candidates, or for any further activity-guided structural 
optimisation to occur, their 2D and 3D molecular architecture must 
be unambiguously determined. This is by no means 
straightforward, given the complex stereostructures associated 
with many marine polyketide natural products, underscored by an 
elaborate isolation procedure that often only generates meagre 
amounts of the novel compound from a huge amount of 
biomass.[7]  
As such, natural product isolation chemists are often faced 
with the daunting task of determining the structure of a complex 
compound and ascertaining its biological activity, all from 
miniscule amounts of material. In the past, with limited 
experimental data, the unambiguous structural elucidation was 
often only achieved through X-ray diffraction studies of single 
crystals of the natural product or derivative. Nowadays, complex 
molecular structures can be solved routinely by chemists 
employing an array of spectroscopic (especially NMR) techniques, 
where previously this may have taken many years to achieve.[8] It 
is no surprise that the overall advancement in natural product 
research has evolved symbiotically with advances in 
characterisation techniques, such that it is now possible to fully 
solve a structure with ever smaller amounts of pure compound. In 
particular, advances in long-range NMR techniques,[9] along with 
detailed conformational analyses from the interpretation of 
coupling constant data of these molecules[10] can be used 
synergistically to reveal the relative configuration of a novel 
chemotype. 
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However, these inferential experimental techniques are 
often insufficient to allow for a full structural determination with 
complete confidence. To alleviate these problems, many state-of-
the-art computational techniques, such as the DP4 NMR 
algorithm,[11] have been developed to allow the application of 
statistical methods in assigning the most likely candidate 
structures for a natural product. Beyond this, recent advances in 
cryo-electron microscopy (EM)[12] have meant that these 
techniques are becoming more relevant for small molecules, 
rather than large biomolecules for which they have already found 
a niche. In the realm of natural products research, the increased 
ease of genome mining has allowed for the use of DNA sequence 
information to help identify the specific enzymes that catalyse 
similar reactions in related compounds, which can often aid in the 
structural elucidation of natural products.[13]  
These aforementioned contemporary structural elucidation 
tools do not provide all the solutions and ab initio computational 
methods, including DP4, become prohibitively costly to run on 
large and especially flexible molecules;[11] the nascent cryo-EM 
technology for small molecules relies on the sample being a solid 
and available in reasonable quantities often not feasible after an 
isolation campaign;[12] and the use of bioinformatics as a 
prospective tool, requires the characterisation of the gene 
sequence encoding the biosynthetic machinery, itself a 
formidable task, especially when the actual producing organism 
may be highly elusive.[14] Even then, these techniques are seldom 
able to fully rationalise the complete stereochemistry of a natural 
product. For these reasons, a targeted synthesis campaign still 
remains the undisputed arbiter of structural proof. Beyond 
chemical derivitisation and degradation, a total synthesis of a 
natural product followed by its spectroscopic comparison with the 
natural sample gives an unambiguous proof of a compound’s 
overall constitution and 3D structure. 
2. The role of synthesis in the stereochemical 
(mis)assignments of complex marine 
polyketide natural products 
As spectroscopic characterisation techniques become more 
advanced and the analytical toolkit becomes more sophisticated, 
it should logically follow that stereochemical assignment errors 
should accordingly decrease. Interestingly, however, taking what 
arguably is the most powerful tool for characterisation – the NMR 
spectrometer, the continual enhancement of an NMR magnet’s 
field strength over the last few decades correlates positively to the 
absolute number of misassignments reported in the literature.[15] 
This seemingly contradictory observation indicates that the 
improvement in sensitivity does not fundamentally alter how 
analyses are conducted. Rather than increasing the accuracy of 
the data analysis and spectroscopic assignments, the correlation 
is attributed to better spectrometers enabling the elucidation of 
increasingly limited amounts from extracts, leading to a greater 
number of new marine and terrestrial natural products isolated.[15] 
Additionally, these structural misassignments often reflect on the 
inherent limitations of each technique, some of which cannot be 
resolved even if a combination of techniques are used.[8] By way 
of example, eventhe seemingly infallible X-ray crystallographic 
technique has its drawbacks. For example, crystallographic 
techniques often struggle to discern between atoms that do not 
contain hydrogen atoms; a fact that led to the structural 
misassignment of the antibiotic kinamycin C (1, Figure 1).[16]  
 
 
Figure 1. Originally reported and revised structure for kinamycin (1) 
In these cases, the nature of inferential structural elucidation 
methods, such as NMR spectroscopy, can be limited in its ability 
to definitively resolve stereochemical ambiguities, as a diverse set 
of isomeric candidates could plausibly be accounted for by the 
same set of spectra.[17] Moreover, the assignment of absolute 
configuration usually requires derivitisation such as by application 
of the modified Mosher method.[18] Because of this, comparative 
methods enabled by targeted synthesis remain as the crowning 
method for stereochemical determination. The power of synthesis 
shines through when discerning between diastereomers, 
especially ones containing distal stereoclusters. In cases where 
the molecule is particularly flexible, ab initio NMR methods often 
cannot generate sufficiently confident answers for which 
structures are likely to be correct, as the plurality of low energy 
conformers often precludes accurate NMR predictions.[11] In these 
cases, the unambiguous stereochemical assignment of a natural 
product is usually achieved through its total synthesis. Prominent 
examples in which the total synthesis of a compound has resulted 
in their structural reassignment include the marine natural 
products callipeltoside A (2, Figure 2) by Paterson[19] and Trost,[20] 
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These synthesis-enabled assignments and reassignments 
have continued to the present day; a cursory search on a literature 
database containing the terms “synthesis” and “stereochemical 
revision/reassignment” generated over 30 results from January 
2016 until the present (August 2019), across a wide range of 
terrestrial and marine natural products. This Minireview highlights 
the prominent role synthesis has played in the stereochemical 
elucidation of a selection of five marine polyketide natural 
products performed in the Paterson group: dolastatin 19, 
dictyostatin, leiodermatolide, phormidolide A and hemicalide. 
 
 
Figure 3. Originally reported and revised structures for azaspiracid-1 
2.1. Synthesis and configurational alignment with 
analogous polyketide natural products enables the 
reassignment of dolastatin 19 and dictyostatin 
The intricacies of polyketide biosynthesis mean that 
structurally similar scaffolds are likely to share a common 
biosynthetic origin. The ability to recognise similar patterns and 
features with related congeners or a ‘biogenesis-guided’ 
elucidation can be a powerful tool in the assignment of complex 
polyketide architectures. Here, two examples from our group are 
presented to demonstrate how a recognition of structurally similar 
features in related marine polyketides led to the configurational 
reassignment of dolastatin 19 and dictyostatin, which were 
ultimately proven through their total syntheses.  
The sea hare Dolabella auricularia affords a wide range of 
bioactive natural products, including the 14-membered 
macrolides aurisides A and B, and the highly cytotoxic peptides 
dolastatins 10 and 15. In 2004, the Pettit group isolated dolastatin 
19 (4, Figure 4),[23] a highly active polyketide from the same 
marine organism. The originally proposed structure for dolastatin 
19 was determined through extensive NMR spectroscopic 
analysis by the isolation group, which revealed a similar 
chemotype to the callipeltosides (vide supra) and aurisides.[23]   
Contrary to these related natural products, however, was the 
recognition that the reported structure for dolastatin 19 was 
epimeric across C5-C7 and C13, which appeared to be 
anomalous with regards to the anticipated common biogenesis of 
these polyketides by the likely cyanobacteria producing 
organism.[24] 
 To probe the stereochemical inconsistencies with related 
congeners, imolecular modelling studies with the macrocyclic 
aglycon variants of the aurisides, callipeltosides and dolastatin 19 
were conducted. This indicated that both the aurisides and the 
callipeltosides adopted a chair conformation for the hemiacetal 
region, whereas the originally proposed structure for dolastatin 19 
adopted a highly distorted boat conformation for the same 
region.[24] These empirical observations alongside the common 
biosynthesis hypothesis led us to putatively reassign the 
stereostructure of dolastatin 19 to 4a, which then needed to be 
unambiguously supported through a total synthesis. To do this, 
the macrolide was disconnected via a late-stage glycosylation 
and macrolactonisation to reveal the seco precursor. This linear 
fragment 5 could then be expeditiously constructed by a series of 
aldol reactions to configure most of the stereocentres. 
 
Figure 4. Originally proposed (4) and reassigned structure (4a) for dolastatin 
19, highlighting the structural homology with related marine macrolides 
 The synthesis of dolastatin 19 commenced with a titanium-





































Azaspiracid-1 (3a): Nicolaou (2006)
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between 6 and 7 to generate adduct 8 (Scheme 1).[25] Subsequent 
manipulation then gave aldehyde 9, which was subjected to a 1,4-
syn boron-mediated aldol reaction[26] with ketone 10 to give 11. 
After engaging in a 1,3-syn reduction and silyl protection, 
fragment 12 was elaborated to aldehyde 13 in anticipation of the 
third boron-mediated aldol reaction with ketone 10, which gave 
the full carbon skeleton 5 of dolastatin 19 with excellent 
diastereoselectivity. From here on, elaboration to the required 
aglycon 14 was attained, which allowed for an interim NMR 
comparison with the natural product and gave an early indication 
of the validity of the proposed reassignment. A final glycosylation 
with 15 followed by silyl deprotection then gave the corrected 
structure 4a for dolastatin 19, which matched the spectroscopic 
data reported for the natural product. Further evidence in support 
of the reassignment included the close agreement of the 
measured specific rotation, in addition to its comparable level of 
cancer cell growth inhibition compared with that originally 
reported by the Pettit group. The total synthesis of dolastatin 19 
(4a), as enabled by our highly stereoselective aldol methodology, 
then secured an unambiguous verification of our biogenesis-
guided structural reassignment. 
 
 
Scheme 1. The total synthesis of dolastatin 19, which confirmed the 
stereochemical reassignment in 4a 
 In 1994, the Pettit group reported the isolation of the marine 
macrolide dictyostatin (16, Figure 5) from an Indian Ocean 
sponge and demonstrated that it displayed potent cancer cell 
growth inhibition at nM concentrations.[27] At the time of its first 
isolation, the planar 22-membered macrolide structure was 
reported. However, inconclusive evidence was given for the 
partial assignment of its stereochemistry. Dictyostatin exhibited 
potent cytotoxicity, even against multidrug-resistant cancer cell 
lines, and represented a highly promising lead as a cancer 
chemotherapeutic agent; all attractive features that led us to 
embark on our synthetic campaign. 
 Following the reisolation of dictyostatin by Wright at the 
Harbor Branch Oceanographic Institution, we determined the 
relative configuration as indicated in 16a through a combination 
of J-based coupling constant analysis and extensive NOE 
experiments.[28] Guided by the striking structural homology 
between the two microtubule-stabilising agents dictyostatin and 
discodermolide (17), it was conjectured that there was likely to be 
a common biogenesis for these polyketides, such that the 
absolute configuration for dictyostatin was putatively assigned as 
in 16a. 
 
Figure 5. Originally proposed (16) and revised structure for dictyostatin (16a), 
highlighting its structural homology with discodermolide (17) 
 We commenced our synthetic campaign by elaborating diol 
18 to iodide 19, which underwent a Myers alkylation[29] with the 
lithium enolate of 20 to afford 21 (Scheme 2).[30] Further 
manipulation gave aldehyde 22, which was subjected to an HWE 
olefination with phosphonate 23 to generate 24. A further 
sequence then afforded the northern hemisphere fragment 25, 
bearing an aldehyde functionality in anticipation of the planned 
Still-Gennari olefination[31] with the southern hemisphere fragment. 
 The synthesis of the southern fragment commenced with a 
Brown asymmetric crotylation[32] of 26 to give 27. A further 
sequence then gave the Still-Gennari type phosphonate 28, which 
underwent an HWE olefination to give 29 with good levels of Z 
selectivity. From here, elaboration by Stille coupling with 
stannane 30, macrolactonisation, Luche reduction and global 
deprotection afforded synthetic dictyostatin (16a), which proved 
to be identical in all respects to an authentic natural sample. Our 
successful total synthesis, alongside that achieved concurrently 
by the Curran group,[33] enabled the unambiguous corroboration 
of the proposed stereochemical assignment. This supported our 
hypothesis for its common biogenesis to discodermolide, and 
subsequently made possible its evaluation as both a potential 









































































































Scheme 2. The total synthesis of dictyostatin, which confirmed the relative and 
absolute configuration of the natural product as 16a 
2.2. Synthesis provides the ultimate proof of configuration 
of leiodermatolide from four candidate stereoisomers 
While being the most powerful spectroscopic technique in 
structural elucidation, NMR-based methods often have their 
limitations in the confident configurational assignment of 
stereocentres. In particular, compounds bearing distally related 
stereocentres often lead to inconclusive assignments. This was 
particularly evident in our synthetic campaign towards 
leiodermatolide (31, Figure 6), a highly potent cytotoxic polyketide 
patented by Wright et al. in 2008.[36] 
In collaboration with the Wright group, we employed 
extensive NMR spectroscopic analysis to separately elucidate the 
configuration of the C6-C9 and C14-C15 regions, contained within 
the 16-membered macrolactone, along with the C21-C25 
stereocluster.[37] The proposed relative configuration of the 
complete macrocycle was then supported by the computational 
DP4 NMR method developed by Smith and Goodman,[11] which 
assigned the macrocyclic diastereomer denoted in Figure 6 with 
>99% probability, and the C21-C25 region with >99% probability. 
However, owing to the spatially distal nature between the C1-C15 
macrocycle and the C21-C25 region, a conclusive assignment 
could not be made between these two regions. This was not 
resolved upon forming the C7,C21 bis Mosher esters, which gave 
inconsistent DdSR signs. Overall, these combined initial efforts 
towards the stereochemical elucidation of (–)-leiodermatolide 
were narrowed down to considering four candidate stereoisomers. 
 
 
Figure 6. Structure of leiodermatolide (31). The relative configuration between 
the macrolactone and the C21-C25 region is arbitrarily defined 
Our synthetic effort began with targeting the leiodermatolide 
macrocycle.[38] Starting with ketone 32 and aldehyde 33, a 
DIPOTf-promoted boron-mediated aldol reaction,[39] followed by 
Evans-Tischenko reduction[40] and protection configured all four 
stereocentres present in the C6-C9 region (34, Scheme 3). A 
further 11 steps were required to generate the C1-C11 stannane 
35. The remaining fragment was synthesised from ketone 36. A 
boron-mediated aldol reaction with aldehyde 37 set the C14-C15 
configuration in 38. Following further manipulation, this gave 
dihalide 39 and stannane 35, which underwent a site-selective 
Stille cross coupling to generate 40. Progression to the seco acid 
41 was followed by macrolactonisation and carbamate installation, 
generating the 22-membered macrocycle 42. The close 1H and 
13C NMR correlation with leiodermatolide provided further support 
for the relative configuration of the macrocycle. However, the (+)-
sign of the specific rotation recorded for 42 was opposite to that 
recorded for (–)-leiodermatolide, tentatively suggesting that the 
synthesis should be retargeted in the enantiomeric series.[41] 
During this time, the Fürstner group reported a total synthesis of 
both candidate diastereomers of leiodermatolide, giving a 
synthetic proof of the relative configuration between the C1-C15 
macrocycle and the C21-C25 region.[42] The comparison between 
the two diastereomers was only made possible through subtle 
peak shape differences in the 1H NMR spectra, leading to their 
synthesis-enabled stereochemical assignment. Additionally, the 
Fürstner synthesis of the correct diastereomer of leiodermatolide 
also matched the specific rotation data, establishing the absolute 
configuration for (–)-leiodermatolide as shown in ent-31. 
Our initial forays towards the leiodermatolide macrocycle 
and the Fürstner group’s timely efforts gave credence towards the 
assignment of the absolute configuration of (–)-leiodermatolide. 
The key lessons learnt from synthesising the macrocycle then 
allowed us to develop a more efficient second-generation route 
towards (–)-leiodermatolide, achieving its total synthesis in 23 
steps and 3.2% overall yield.[43] 
Leiodermatolide stands as a testament towards the 
combined power of experimental NMR and computational 
methods in aiding the stereochemical assignment of complex 
polyketide natural products. However, even this has its limitations, 
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assignment of configuration ultimately rested upon its successful 
total synthesis, demonstrating once again the role synthesis plays 
as the ultimate arbiter of structure. 
 
Scheme 3. Synthesis of the macrocyclic core of (–)-leiodermatolide 42, which 
gave the contrasting chiroptical data as compared with the natural product 
2.3. A serendipitous outcome from a vinyl Grignard 
aldehyde addition leads to the stereochemical reassignment 
of phormidolide A 
Occasionally, misassignments can still arise due to the 
stereochemical complexity of the natural product that are not 
ameliorated by advances in characterisation techniques. 
Phormidolide A is an example of this. In the initial isolation report 
by the Gerwick group, a comprehensive elucidation of its 3D 
structure was described,[44] which was apparently corroborated by 
its biosynthesis in a subsequent paper.[45] During our ongoing 
synthetic campaign in collaboration with the Britton group towards 
this intriguing polyketide, a combination of an unexpected 
reaction outcome and its subsequent investigation led to the 
configurational reassignment of phormidolide A. 
Phormidolide A (43, Figure 7) was isolated from the marine 
cyanobacteria Leptolyngbya sp. collected off the coast of 
Sulawesi, Indonesia. Interestingly, phormidolide A was found to 
be inactive in the National Cancer Institute (NCI) in vitro 60-cell 
line assay, though it did exhibit potent brine shrimp toxicity (LD50 
= 1.5 µM). It was surmised that phormidolide A may have an 
adaptive significance for the organism, perhaps playing a role in 
deterring predators.[44] At the time, the proposed 3D structure of 
phormidolide A was wholly determined by NMR methods via J-
based coupling constant analysis as well as by the preparation of 
the triacetonide derivative 44. At the outset of our synthesis 
campaign, we recognised that the original J-based coupling 
constant analysis contained several inconsistencies, notably 
providing inconclusive evidence for assigning the relative 
configuration between the C1-C17 macrolactone and the C18-
C33 side chain. As the assigned absolute configuration of the 
macrocycle was deemed secure from Mosher ester analysis, the 
two enantiomeric forms of the side chain were targeted to probe 




Figure 7. Proposed structure (43) of phormidolide A and its triacetonide 
derivative 44 
Hypothesising that the reported C17 configuration could be 
installed via a chelation-controlled vinylmetal addition to a suitable 
THF aldehyde, disconnection across the C17-C18 bond revealed 
the C1-C17 macrolactone, and a truncated side chain fragment – 
affording the C18-C23 vinyl iodide as the planned vinylmetal 
precursor.[46] Starting from aldehyde 45 and ketene silyl acetal 46, 
an asymmetric Mukaiyama aldol reaction using a valine-derived 
oxazaborolidinone mediator[47] gave enantioenriched 47, with the 
absolute configuration dictated by the use of either D- or L-valine 
(Scheme 4). From here, three more steps were required to give 
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Scheme 4. Synthesis of the model side chain fragment 48 and ent-48 
The macrolactone was similarly simplified, truncating it to a 
model C10-C17 aldehyde 49 bearing a dimethylacrylate ester as 
a surrogate for the macrolactone linkage. The synthesis of 49 
commenced with an asymmetric L-proline-mediated aldol 
reaction[48] between aldehyde 50 and dioxanone 51 to afford 
chlorohydrin 52 (Scheme 5). A subsequent methyl Grignard 
addition followed by cyclisation of 53 gave the functionalised THF 
core 54, which was further manipulated to give the suitably 
configured intermediate 55. The C15 alcohol in 55 was then 
esterified with acid 56, followed by conversion into the model 
aldehyde 49 to investigate the vinylmetal addition. 
 
 
Scheme 5. Synthesis of the model aldehyde 49 
Vinyl iodide 48 was transformed to the corresponding 
Grignard reagent and a chelation-controlled addition with 
MgBr2·OEt2 into aldehyde 49 was conducted (Scheme 6). The 
stereochemistry of the resulting adduct 58a was then determined 
by conversion into the corresponding diacetonide 59a,[49] which 
surprisingly bore the 17R configuration, epimeric to the expected 
17S configuration required for phormidolide A. The sense of 
stereocontrol arising from chelation was confirmed by omitting the 
addition of MgBr2·OEt2. This delivered predominantly the epimeric 
17S configuration in 58b arising from polar Felkin-Anh control, 
which gave the corresponding diacetonide 59b. Interestingly, 
NMR comparison of 59a and 59b (containing the reported 17S 
configuration) with the triacetonide derivative 44 showed that 59a 
bearing the epimeric 17R configuration was in fact a very good 
match with 44! Here, a reanalysis of the original NMR data of 
phormidolide A and its triacetonide supported the conclusion that 
C17 was misassigned. To then probe whether or not the 
remainder of the side chain required reassignment, the analogous 
adduct 58c and its corresponding diacetonide 59c were 
synthesised. Detailed NMR comparison of 59a and 59c with 
phormidolide A triacetonide 44 revealed that diacetonide 59c, 
which contained the inverted C17 and C21 configuration, best 
matched the natural product, resulting in a reassignment of seven 
of the 11 stereocentres in phormidolide A (43a, Figure 8). 
 
 
Scheme 6. Synthesis of the diastereomeric diacetonides 59a-c revealed 59c 
being the best match with phormidolide A triacetonide 44 
This reassignment was particularly notable in light of the fact 
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reported.[45] In this study, the stereochemistry for phormidolide A 
was hypothesised to be set by the action of ketoreductase 
enzymes. In the originally proposed structure (43) of phormidolide 
A, all carbinol stereocentres are L-configured (Figure 8). This 
contradicts the assignment predicted by the ketoreductase 
sequences, which based on analogous ketoreductases indicates 
that they should likely be D-configured. Our synthesis-based 
detective work reassigns these L-configured carbinol centres to 
their corresponding D-configuration in 43a, which now better 
rationalises the stereochemistry of phormidolide A. This example 
neatly highlights the decisive role synthesis can play in the 




Figure 8. The reassigned structure of phormidolide A (43a) now more closely 
aligns with the ketoreductase data presented by the Gerwick group.[45] 
2.4. A combination of synthesis and computational methods 
enables the ongoing stereochemical elucidation of 
hemicalide 
The continual advances in computational NMR methods 
has resulted in its increasing uptake to assist in structural 
elucidation. As illustrated with leiodermatolide, the DP4 
parameter introduced by Smith and Goodman[11] successfully 
allowed for the corroboration of the macrocyclic stereochemistry 
in leiodermatolide. More recently, the Aggarwal group 
demonstrated just how powerful a synergistic combination of 
computational methods and synthesis is in their landmark 
stereochemical elucidation of the baulamycins.[50] In this final 
example, we demonstrate that it is through combination of 
synthesis and computational NMR methods that we were able to 
successfully tackle a seemingly intractable number of 
stereoisomers presented by the natural product hemicalide. 
First appearing in the patent literature in 2011, hemicalide 
(60, Figure 9) was isolated from the marine sponge Hemimycale 
sp. collected around the Torres Islands of Vanuatu by CNRS-
Pierre Fabre Laboratories and the Institut de Recherche pour le 
Développement.[51] Preliminary biological studies on hemicalide 
revealed its extraordinary biological activity, registering pM levels 
of cytotoxicity across a panel of cancer cell lines. Initial 
characterisation revealed a 46-carbon skeleton possessing 21 
stereocentres. Unfortunately, further derivatisation or degradation 
studies to ascertain both its relative and absolute configuration 
were not conducted, owing to the scarce supply of material, 
leaving all 21 stereocentres unassigned to produce 221 (or over 2 
million!) possible stereoisomers.  
To simplify the task of ascertaining the relative configuration 
of hemicalide, the Ardisson and Cossy groups began by 
examining isolated stereoclusters, notably the C8-C13 
polypropionate,[52] the C18-C24 dihydroxylactone[53] and the C36-
C46 hydroxylactone[54] regions (Figure 9) and determining their 
likely configurations through the synthesis of model fragments, 
which resulted in the assignments shown in 61, 62 and 63. In 
collaboration with the Goodman group, we independently began 
tackling the stereoconundrum of hemicalide by targeting the same 
stereochemically rich regions through comparing ab initio 
generated NMR chemical shifts of candidate diastereomers and 
calculating a probability for a confident assignment using the DP4 
method. This study corroborated the assignments of the C8-C13 
region 61 and the C36-C46 region 63, but returned the 18,19-syn 
configuration in 62a as the most likely candidate diastereomer 
(99%) for the dihydroxylactone region,[55] with the configuration 




Figure 9. Planar structure of hemicalide (60), initial analysis by Ardisson/Cossy 
followed by DP4 studies conducted by the Paterson/Goodman groups 
resulting in the preliminary reassignment of 62 to 62a 
In light of this incongruous result, we sought to corroborate 
the DP4 prediction through a targeted synthesis of a model 
dihydroxylactone truncate 63 (Scheme 7). This commenced with 
a DIPCl-mediated boron-mediated aldol reaction between 
aldehyde 64 and ketone 65, both derived from the same 












LL L L LL
L
Reassignment now
aligns with ketoreductase data,











Seven of 11 stereocentres reassigned
L











































































sequence involving protection, aldol addition, lactonisation and 
dehydration afforded 68. This could be dihydroxylated to install 
the final two stereocentres in fragment 69. At this point, a Stille 
cross-coupling with stannane 70 generated model fragment 63, 
containing the 18,19-syn configuration, which gratifyingly gave a 
much closer spectroscopic match to the natural product than the 
original assignment proposed by Ardisson in 62. 
 
 
Scheme 7. Synthesis of model truncate 63 for NMR comparison revealed that 
hemicalide possesses the 18,19-syn configuration 
So far, the combined work of the Ardisson/Cossy teams and 
ourselves has resulted in the elucidation of 16 out of the 21 
stereocentres in hemicalide, leaving the C27-C32 region (four 
stereocentres) and the isolated C45 stereocentre unassigned. 
Additionally, the relative configuration between each stereocluster 
remains undetermined. The latter problem was initially probed 
computationally, but this was found to be impractical given the 
size and flexibility of the truncates in question. Therefore, we 
turned to synthesis to help solve this stereoconundrum. 
Specifically, we aimed to generate two candidate diastereomers 
for the C1-C28 fragment containing the C1-C15 region and the 
revised C16-C24 region. From intermediate ent-69, the 
completion of the C16-C28 fragment 71 required five steps 
(Scheme 8),[55] and this was planned to undergo an analogous 
Stille coupling with a suitable C1-C15 stannane 72. The 
construction of the C1-C15 stannane 72 commenced with an 
Evans syn aldol[56] with aldehyde 73 and 74 to generate adduct 
75.[57] Subsequent manipulations revealed aldehyde 76, which 
engaged with ketone ent-32 via a 1,4-syn boron-mediated aldol 
reaction[58] to give 77. Following protection, the final stereocentre 
was set through a diastereoselective reduction to generate 
fragment 78. The full C1-C15 stannane coupling partner 72 was 
then elaborated from 78 in five steps. Notably, the uniformly high 
diastereoselectivity of this route permitted the synthesis of both 
enantiomers of the C1-C15 fragment (72 and ent-72) required to 
probe the configurational relationship between the C1-C15 and 
the C16-C24 region. 
 
Scheme 8. Synthesis of vinyl iodide 71 and vinyl stannane 72 
By coupling 71 with either 72 or ent-72, the 13,18-syn and 
13,18-anti diastereomers 79a and 79b of the C1-C28 region were 
obtained (Scheme 9). These were then transformed into model 
acid truncates 80a and 80b. Detailed 1H and 13C NMR 
comparisons between 80a, 80b with hemicalide revealed that the 
13,18-syn configuration in 80a was a much closer match than the 
alternative 13,18-anti configuration in 80b. This reduces the 
number of candidate stereoisomers to consider from over two 
million at the outset of this ambitious project down to 128. This 
result demonstrates that NMR spectroscopic analyses of well-
designed synthetic truncates can discern between diastereomers 
possessing distally related stereoclusters that may otherwise be 
difficult to achieve via inferential means. Finally, it is worth noting 
that the combined Ardisson/Cossy/Meyer teams have recently 
prepared the partially deprotected full carbon skeleton of a 
diastereomer of hemicalide, bearing the incorrect 13,18-anti 
relationship, which resulted in a poor NMR spectroscopic 
correlation relative to the C27-C32 region of the natural 
product.[59] In addition to the conclusions presented above, this 
gives credence to the idea that a wholly synthesis-based 
configurational elucidation of hemicalide is indeed possible. 
3. Summary and Outlook 
The continual advances in small molecule spectroscopic 
characterisation techniques have facilitated a much greater 
structural diversity of compounds to be isolated and elucidated 
from marine organisms. This, in turn, has inspired the 
development of state-of-the-art analytical methods on microscale, 
as well as novel synthetic methods for their de novo 
stereocontrolled construction. However, these contemporary 
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still happen. In many cases, advanced techniques are unable to 
resolve stereochemical ambiguities, and a judicious synthetic 
chemistry campaign can still be used as the final tool to definitively 
pin down a novel compound’s true identity.  
 
 
Scheme 9. The synthesis of model truncates 80a and 80b for NMR 
comparison resulted in the 13,18-syn assignment between the C1-C15 region 
and the C16-C24 region 
The aforementioned five detective stories from our own 
research[60] are among a multitude of examples in the chemical 
literature on the decisive role synthesis has played in the 
unambiguous stereochemical assignment of natural products. In 
cases where related natural products have been isolated, 
homology from biosynthetic proposals can guide a synthesis-
enabled reassignment, as evidenced by the reassignment of 
dolastatin 19 and dictyostatin. The recent advances in 
computational NMR methods was an enabling factor for our 
stereochemical assignment of leiodermatolide, which led to a 
manageable number of diastereomers to tackle in a focused total 
synthesis campaign. In the absence of other chemical or 
bioinformatic methods, the resulting total syntheses of (–)-
leiodermatolide also demonstrate the important role of 
enantiospecific synthesis in assigning the absolute configuration. 
The synthesis-enabled stereochemical reassignment of 
phormidolide A highlights the precarity of complex natural product 
structural elucidation. In the end, it was through the serendipitous 
stereochemical outcome of a pivotal vinyl Grignard aldehyde 
addition that led us to reassign seven of its 11 stereocentres. 
Finally, the complete lack of stereochemical information (and 
characterisation data!) available for hemicalide required a 
synergy of computational and synthetic approaches to 
incrementally illuminate its configuration. In this example, we 
demonstrated the power of computational NMR methods in 
elucidating the relative configuration within fragments. However, 
extending this method towards larger fragments proved 
impractical, and the ultimate proof-of-configuration in the C1-C28 
region lay in its successful stereodefined synthesis. Echoing the 
example presented in leiodermatolide, detailed 1H and 13C NMR 
analysis of both diastereomers revealed distinct but small 
chemical shift differences for the 1,6-related stereoclusters. In the 
absence of crystallographic or microscopic techniques, being able 
to distinguish between distally related stereoclusters in flexible 
systems remains a feat that would be difficult to achieve, even 
with the most advanced characterisation methods available today.  
The impact natural product chemistry has had on humanity 
is undeniable, and the relative infancy alongside some high-
profile successes of marine natural products marks it as a fertile 
field for the continual discovery of promising new chemical entities 
as drug leads. With their ornate molecular architectures, as 
exemplified by phormidolide A and hemicalide, their confident 
stereochemical elucidation will remain as an enduring challenge 
for practitioners in natural products research. On top of its further 
role of alleviating the supply problem presented by most marine 
natural products, organic synthesis offers a uniquely powerful tool 
for their stereochemical elucidation. It goes to show that the 
symbiotic relationship between synthetic organic and natural 
product chemistry will only serve to mutually benefit each other in 
our ongoing quest to find more effective disease-alleviating 
agents in improving the condition of humankind. 
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Through the judicious use of 
stereocontrolled transformations in 
combination with detailed 
experimental and computational 
NMR studies, this Minireview 
highlights recent synthetic work on 
stereochemically ambiguous marine 
polyketide natural products that has 
resulted in their configurational 
assignments and reassignments. 
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